N-[3-[(3-nitrophenyl)methylsulfinyl]phenyl]-1-benzofuran-2-sulfonamide
C21H16N2O6S2 — CID 151797824
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[(3-nitrophenyl)methylsulfinyl]phenyl]-1-benzofuran-2-sulfonamide
N-[3-[(3-nitrophenyl)methylsulfinyl]phenyl]-1-benzofuran-2-sulfonamide (PubChem CID 151797824) has the molecular formula C21H16N2O6S2 and a molecular weight of 456.50 g/mol. Its IUPAC name is N-[3-[(3-nitrophenyl)methylsulfinyl]phenyl]-1-benzofuran-2-sulfonamide.
Molecular Properties
| Compound Name | N-[3-[(3-nitrophenyl)methylsulfinyl]phenyl]-1-benzofuran-2-sulfonamide |
|---|---|
| PubChem CID | 151797824 |
| Molecular Formula | C21H16N2O6S2 |
| Molecular Weight | 456.50 g/mol |
| Exact Mass | 456.04 |
| IUPAC Name | N-[3-[(3-nitrophenyl)methylsulfinyl]phenyl]-1-benzofuran-2-sulfonamide |
| SMILES | O=[N+]([O-])c1cccc(CS(=O)c2cccc(NS(=O)(=O)c3cc4ccccc4o3)c2)c1 |
| InChI | InChI=1S/C21H16N2O6S2/c24-23(25)18-8-3-5-15(11-18)14-30(26)19-9-4-7-17(13-19)22-31(27,28)21-12-16-6-1-2-10-20(16)29-21/h1-13,22H,14H2 |
| InChIKey | RXYXPDVYKSYBNB-UHFFFAOYSA-N |
| XLogP | 4.45 |
| TPSA | 119.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.50 |
| LogP ≤ 5 | 4.45 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151797824 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.